Shanghai Pharmaceuticals Holding Co (2607) Financial Statements

5 Followers

Shanghai Pharmaceuticals Holding Co Financial Overview

Shanghai Pharmaceuticals Holding Co's market cap is currently HK$65.58B. The company's EPS TTM is HK$0.18120450568; its P/E ratio is 16.41; and it has a dividend yield of 2.67%. Shanghai Pharmaceuticals Holding Co is scheduled to report earnings on March 29, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 283.58B	¥ 275.25B	¥ 260.30B	¥ 231.98B	¥ 215.82B
Gross Profit	¥ 30.42B	¥ 30.63B	¥ 30.93B	¥ 30.49B	¥ 28.54B
Operating Income	¥ 9.94B	¥ 8.14B	¥ 7.67B	¥ 9.01B	¥ 8.21B
EBITDA	¥ 14.37B	¥ 12.06B	¥ 10.90B	¥ 12.44B	¥ 10.55B
Net Income	¥ 5.72B	¥ 4.55B	¥ 3.77B	¥ 5.62B	¥ 5.09B
Balance Sheet
Cash & Short-Term Investments	¥ 43.08B	¥ 44.38B	¥ 40.67B	¥ 37.01B	¥ 22.39B
Total Assets	¥ 233.15B	¥ 221.21B	¥ 211.97B	¥ 198.13B	¥ 163.44B
Total Debt	¥ 49.48B	¥ 47.79B	¥ 42.90B	¥ 38.56B	¥ 31.69B
Net Debt	¥ 16.76B	¥ 12.05B	¥ 12.38B	¥ 11.16B	¥ 9.30B
Total Liabilities	¥ 143.36B	¥ 137.47B	¥ 131.65B	¥ 120.13B	¥ 104.37B
Stockholders' Equity	¥ 75.89B	¥ 71.68B	¥ 68.52B	¥ 67.06B	¥ 49.36B
Cash Flow
Free Cash Flow	¥ 3.83B	¥ 3.43B	¥ 2.26B	¥ 2.06B	¥ 942.55M
Operating Cash Flow	¥ 6.15B	¥ 5.83B	¥ 5.23B	¥ 4.74B	¥ 5.06B
Investing Cash Flow	¥ -3.98B	¥ 415.98M	¥ -2.49B	¥ -12.47B	¥ -6.02B
Financing Cash Flow	¥ -5.65B	¥ -1.86B	¥ 231.85M	¥ 12.14B	¥ 1.57B

Currency in CNY

Shanghai Pharmaceuticals Holding Co Earnings and Revenue History

Income Statement >

Shanghai Pharmaceuticals Holding Co Debt to Assets

Balance Sheet >

Shanghai Pharmaceuticals Holding Co Cash Flow

Cash Flow >

Shanghai Pharmaceuticals Holding Co Forecast EPS vs Actual EPS

Earnings >